Tofacitinib in interstitial lung disease complicated with anti-MDA5 antibody-positive dermatomyositis: A literature review

Tofacitinib in interstitial lung disease complicated with anti-MDA5 antibody-positive dermatomyositis: A literature review Get access Satoshi Takanashi, Satoshi Takanashi Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan https://orcid.org/0000-0002-3607-2140 Search for other works by this author on: Oxford Academic Google Scholar Yuko Kaneko, Yuko Kaneko Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan Search for other works by this author on: Oxford Academic Google Scholar Tsutomu Takeuchi Tsutomu Takeuchi Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan CONTACT Tsutomu Takeuchi tsutake@z5.keio.jp Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan Search for other works by this author on: Oxford Academic Google Scholar Modern Rheumatology, Volume 32, Issue 1, January 2022, Pages 231–237, https://doi.org/10.1080/14397595.2021.1906505 Published: 15 April 2021 Article history Received: 12 February 2021 Accepted: 13 March 2021 Published: 15 April 2021